- The anticoagulants market may derive substantial growth
through the forecast period of 2018-2026 from the rising geriatric
population and escalating investment in research and development
activities
- Based on an extensive analysis of all factors, the global
anticoagulants market is expected to expand at a CAGR of 8.0 % from
2018 to 2026
ALBANY, N.Y., Oct. 19, 2020 /PRNewswire/ -- Anticoagulants
are utilized to eliminate the threat of blood clots in the body.
When blood clots are formed in the blood vessels, they can block
blood circulation. This situation leads to heart attacks and
strokes. To prevent all this, anticoagulants are used on a large
scale by a considerable populace.
Anticoagulants Market: Current and Future Growth
Insights
Obesity has become a grave problem across the globe. According
to the World Health Organization (WHO), 39 percent of adults (18
years and above) were overweight, and 13 percent were obese in
2016. WHO also states that worldwide obesity has almost tripled
since 1975. These statistics highlight the growing prevalence of
obesity.
With obesity, a large number of diseases and disorders are
likely to prevail all over the body. This is where anticoagulants
are used. Hence, with the escalating obesity cases, the
anticoagulant market is expected to gain good growth over the
forecast period.
Request for Analysis of COVID-19 Impact on Anticoagulants
Market –
https://www.transparencymarketresearch.com/covid19.php
After a detailed analysis of all factors and parameters related
to growth, the researchers at Transparency Market Research (TMR)
foresee the global anticoagulants market to record a robust CAGR of
8.0 percent through the assessment period of 2018-2026. The global
anticoagulants market was valued at US$
21,759.3 mn in 2018.
Supportive government policies, extensive investment by many
investors and heightening geriatric population may serve as
prominent growth pillars of the anticoagulants market. The
development of novel technologies through expansive research forms
a great bond of growth.
Request Brochure of Anticoagulants Market Report -
https://www.transparencymarketresearch.com/brochure.php
Anticoagulants Market: Vital Findings
- Based on drug class, the factor Xa inhibitors (NOAC/DOAC)
segment may expand at a high CAGR
- In regards to indication, the arterial fibrillation and heart
attack segment may incur good growth for the anticoagulants market
through the forecast period of 2018-2026
- Hospital pharmacies segment in distribution channel may
generate profitable growth for the anticoagulants market between
2018 and 2026
- North America was the dominant
regional growth contributor in 2017and is expected to continue the
same run during this forecast period
- Europe emerged as the
second-largest regional growth contributor in 2017
- Asia Pacific bagged the third
place in terms of regional growth contribution in 2017
Explore 159 pages of superlative research, current market
scenario, and extensive geographical projections. Gain insights
into the Anticoagulants Market (Route of Administration - Oral,
Injectables; Drug Class - Factor XA Inhibitors (NOAC/DOAC),
Heparins, Direct Thrombin Inhibitors, Vitamin K Antagonists;
Indication - Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE),
Atrial Fibrillation and Heart Attack; Distribution Channel -
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Global
Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 -
2026 at
https://www.transparencymarketresearch.com/report-toc/60924
Anticoagulants Market: Growth Propellers
As stress, anxiety, and obesity are prevalent among a large
populace worldwide, chronic diseases continue to escalate. This
aspect will serve as a prime growth influencer for the
anticoagulants market over the forecast period of 2018-2026.
- Online pharmacies are on the rise, and this aspect will invite
expansive growth opportunities for the anticoagulants market
- Unhealthy lifestyle is present among a substantial populace,
eventually increasing the growth prospects across the
anticoagulants market
- Provision of financial aid by established players to purchase
anticoagulants may invite significant growth opportunities for the
anticoagulants market
Purchase the Anticoagulants Market Report -
https://www.transparencymarketresearch.com/checkout.php
Anticoagulants Market: Growth Restraints
Some of the major growth restraints revolving around the
anticoagulants market are as follows:
- The popularity of conventional drugs such as warfarin in
developing countries
- Side effects caused by consuming certain types of
anticoagulants, such as nausea, bleeding, and vomiting may hinder
the market to a certain extent
- The high cost of NOACs may serve as a major growth dampener
across developing countries like India, China,
Brazil, and others
Browse More Press Release -
https://www.transparencymarketresearch.com/press-releases.htm
The global anticoagulants market has been segmented as
follows:
By Administration
- Oral
- Injectables
- By Drug Class
- Factor XA Inhibitors (NOAC/DOAC)
- Heparins
- Direct Thrombin Inhibitors
- Vitamin K Antagonists
By Indication
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism (PE)
- Atrial Fibrillation & Heart Attack
- Others
By Distribution channel
- Hospital
- Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Explore Transparency Market Research's award-winning coverage
of the global Healthcare Industry:
Anticoagulant Reversal Drugs Market: Rise in prevalence of
atrial fibrillation among the geriatric population, increase in
occurrence of intracranial hemorrhage and gastrointestinal
hemorrhage, and surge in the number of cases of warfarin therapy
requiring reversal of anticoagulants boost the growth of the global
market
Stroke Treatment Market: Manufacturers in the stroke treatment
market are introducing reversal drug agents that minimize the
incidence of life-threatening or uncontrolled bleeding in patients.
Healthcare providers recommend the consumption of reversal agents
in case oral anticoagulants are insufficient to treat stroke
patients
Injectable Anticoagulants Market: Rise in incidence of
coagulation and renal and heart diseases, commercialization of safe
and cost-effective biological origin anti-coagulants, enhanced
quality control measures, increase in geriatric population, and
surge in investment in research and development of biological
origin drugs drive the injectable anticoagulants market
Browse Our Latest Reports -
https://www.transparencymarketresearch.com/latest.htm
About Transparency Market Research
Transparency Market Research is a next-generation market
intelligence provider, offering fact-based solutions to business
leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow,
evolve, and mature. Our real-time data collection methods along
with ability to track more than one million high growth niche
products are aligned with your aims. The detailed and proprietary
statistical models used by our analysts offer insights for making
right decision in the shortest span of time. For organizations that
require specific but comprehensive information we offer customized
solutions through adhoc reports. These requests are delivered with
the perfect combination of right sense of fact-oriented problem
solving methodologies and leveraging existing data
repositories.
TMR believes that unison of solutions for clients-specific
problems with right methodology of research is the key
to help enterprises reach right decision."
Browse More Upcoming Reports by Transparency Market
Research: https://www.transparencymarketresearch.com/upcoming.htm
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free:
866-552-3453
Email: sales@transparencymarketresearch.com
Press Release
Source: https://www.transparencymarketresearch.com/pressrelease/anticoagulants-marke.htm
Website:
https://www.transparencymarketresearch.com/
Logo:
https://mma.prnewswire.com/media/1085206/Transparency_Market_Research_Logo.jpg